|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D12.3 |
Benign neoplasm of transverse colon
|
D123 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 11.25%
|
36.23%
|
27.21%
|
13.44%
|
5.80%
|
2.73%
|
1.38%
|
0.75%
|
0.40%
|
0.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D12.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
35,084
|
71,194
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
20,519
|
769,015
|
|
45385
|
COLONOSCOPY W/LESION REMOVAL |
18,541
|
18,542
|
|
45380
|
COLONOSCOPY AND BIOPSY |
13,999
|
13,998
|
|
J7120
|
RINGERS LACTATE INFUSION |
6,553
|
7,412
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
5,680
|
23,752
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
5,605
|
5,605
|
|
J3010
|
FENTANYL CITRATE INJECTION |
5,113
|
8,412
|
|
J2001
|
LIDOCAINE INJECTION |
3,889
|
32,318
|
|
82962
|
GLUCOSE BLOOD TEST |
2,905
|
3,186
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
2,878
|
3,169
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
2,313
|
6,878
|
|
G0500
|
MOD SEDAT ENDO SERVICE >5YRS |
2,242
|
2,243
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
2,075
|
2,429
|
|
45381
|
COLONOSCOPY SUBMUCOUS NJX |
1,707
|
1,707
|
|
99153
|
MOD SED SAME PHYS/QHP EA |
1,698
|
2,725
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,603
|
6,674
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,508
|
1,517
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
1,453
|
1,455
|
|
J2370
|
PHENYLEPHRINE HCL INJECTION |
1,303
|
4,164
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D12.3 related to the following DRG Codes:
393-395
|
